A Multicenter Study to Evaluate the Nutritional Suitability of Renastart (Renastart)
A Multicenter, Open Label, Uncontrolled Study to Evaluate the Acceptability, Tolerability and Nutritional Suitability of Renastart: Specially Formulated to Meet the Unique Nutritional Needs From Birth to 10 Years With Chronic Kidney Disease
Sponsor: Vitaflo International, Ltd
This NA trial investigates Chronic Kidney Disease and Hyperkalemia and is currently completed. Vitaflo International, Ltd leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2024 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2024 [monthly]
Completed NA
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 5 earlier versions
-
May 2019 — Jul 2020 [monthly]
Recruiting NA
-
Oct 2018 — May 2019 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — May 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Vitaflo International, Ltd
For direct contact, visit the study record on ClinicalTrials.gov .